噻嗪类利尿剂使用与骨折风险:队列研究的荟萃分析
该荟萃分析纳入11项前瞻性队列研究共2,193,160名参与者,发现噻嗪类利尿剂使用者较非使用者全骨折风险降低14%(RR 0.86,95%CI 0.80-0.93,p=0.009),髋部骨折风险降低18%(RR 0.82,95%CI 0.80-0.93,p=0.009);作者认为噻嗪类可能降低骨折风险,临床处方时应考虑其保护作用。
要点
- 噻嗪类使用者较非使用者全骨折风险降低14%(RR 0.86,95%CI 0.80-0.93,p=0.009)。
- 噻嗪类使用者较非使用者髋部骨折风险降低18%(RR 0.82,95%CI 0.80-0.93,p=0.009)。
- 作者认为噻嗪类可能降低骨折风险,临床处方时应考虑该保护作用。
核心结论
- 作者认为噻嗪类利尿剂使用可能降低骨折风险,临床处方噻嗪类利尿剂时应考虑该保护作用。
研究设计与样本
- 更新版荟萃分析,检索MEDLINE、EMBASE、SCOPUS和Cochrane系统评价数据库,纳入从建库至2017年5月1日发表的队列研究。
- 文献检索、研究筛选、研究评价和数据提取在方案中预先定义,由两名研究者独立完成。
- 因原始研究存在异质性,采用随机效应模型合并混杂因素校正后的相对风险(RR)。
- 共纳入11项合格队列研究,涉及2,193,160名参与者。
主要发现
- 总体而言,噻嗪类利尿剂使用者较非使用者全骨折风险显著降低14%(RR 0.86,95%CI 0.80-0.93,p=0.009)。
- 噻嗪类使用者较非使用者髋部骨折风险降低18%(RR 0.82,95%CI 0.80-0.93,p=0.009)。
- 仅限高质量原始研究(质量评分>8)时,噻嗪类相关效应量略减弱(RR 0.89,95%CI 0.80-0.99,p=0.005)。
- 仅限样本量较大(>10,000)的研究时,效应量略减弱(RR 0.90,95%CI 0.80-1.00,p=0.002)。
- 仅限2007年后发表的研究时,效应量略减弱(RR 0.92,95%CI 0.82-1.02,p=0.001)。
临床怎么用
- 作者认为,临床处方噻嗪类利尿剂时应考虑该类药物可能降低骨折风险的保护作用。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Inconsistent findings in regard to association between thiazide diuretic use and the risk of fracture have been reported during the past decade. This updated meta-analysis, which pooled data from 11 qualified prospective designed studies, found that thiazides have a significant protective effect on fracture risk. INTRODUCTION: An updated comprehensive meta-analysis examine the association between thiazide diuretic use and therisk of fracture is needed. METHODS: Cohort studies regarding thiazide diuretic exposure and the risk of fracture, published from inception to May 1 2017, were identified through MEDLINE, EMBASE, SCOPUS, and the Cochrane Database of Systematic Reviews. The literature search, study selection, study appraisal, and data extraction were pre-defined in the protocol and were independently conducted by two investigators. Due to the heterogeneity of the original studies, a random effects model was used to pool the confounder-adjusted relative risk (RR). RESULTS: Eleven eligible cohort studies involving 2,193,160 participants were included for analysis. Overall, thiazide diuretic users, as compared with non-users, had a significant 14% reduction in the risk of all fractures (relative risk [RR], 0.86; 95% confidence interval [CI], 0.80-0.93; p = 0.009) and an 18% reduction in the risk of hip fracture (RR, 0.82; 95%CI, 0.80-0.93; p = 0.009). However, the effect size associated with thiazide use became slightly weaker when the analysis was limited to only high-quality original studies (quality score > 8) (RR, 0.89; 95%CI, 0.80-0.99; p = 0.005), studies with a larger sample size (> 10,000) (RR, 0.90; 95%CI, 0.80-1.00; p = 0.002), and studies published after 2007 (RR, 0.92; 95%CI, 0.82-1.02; p = 0.001). CONCLUSION: Our findings indicate that thiazide diuretic use may convey a decreased risk of fracture and as such, the protective effect of this class of medicine should be considered when prescribing thiazide diuretics in clinical practice.
引用
- Xiao X, Xu Y, Wu Q, et al. Thiazide diuretic usage and risk of fracture: a meta-analysis of cohort studies. Osteoporos Int. 2018. PMID: 29574519. doi:10.1007/s00198-018-4486-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。